MoneyWorks4Me

Nectar Lifesciences informs about disclosure

10 Jan 2025 Evaluate
Nectar Lifesciences has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ingain Traders LLC, Vedanta Opportunities Fund LP, Isengard Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1769.10
Dr. Reddys Labs. 1239.65
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1131.00
View more..